The Psio and Alzheimer’s
Regression of Alzheimer’s Disease
Alzheimer’s disease is a progressive neurodegenerative disorder that affects the brain. It is characterized by memory loss and a gradual decline in cognitive functions such as reasoning, abstract thinking, understanding, language use, and changes in behavior and mood.
Alzheimer’s is caused by an accumulation of abnormal proteins in the brain, leading to the death of brain cells. Until recently, there was no curative treatment for Alzheimer’s disease.
However, over the past decade, a revolution has been underway in reversing the effects of this devastating disease, which affects 8% of people over the age of 65. This significant regression is achieved through light stimulation at 40 hertz, combined with a 470 nm blue wavelength—already commonly used in PSiO technology to stimulate the pineal gland.
The PSiO 3.0 glasses have been specifically designed to meet the specifications developed through extensive studies.
These studies demonstrate a reduction in amyloid plaques and neurovegetative disorders, characterized by the abnormal accumulation of certain proteins on neurons.
Below are some articles summarizing ongoing studies on Alzheimer’s disease:
Stimulating the brain at 40 Hz to treat Alzheimer’s disease.
What if exposure to 40 Hz light and sound could promote a healthier brain? That’s the hypothesis of scientists at The Picower Institute for Learning and Memory at Massachusetts Institute of Technology (MIT).
[ Download the PDF for printing.]40Hz : la fréquence que le cerveau adore et qui lutte contre Alzheimer.
Une fréquence particulière, de 40 Hz joue un rôle central dans les fonctions cérébrales. le cerveau marche au mieux avec cette fréquence et elle lutte contre Alzheimer.
[ Download the PDF for printing.]The Idea Behind Using Masked 40 Hz, Light Based Brain Stimulation for Alzheimer Disease.
Marcus Carstensen, PhD candidate, CTO and co-founder of OptoCeutics in Copenhagen, Denmark, talked about the mechanisms of using noninvasive light technologies for Alzheimer disease treatment.
[ Download the PDF for printing. ]
All studies and articles can be accessed on the PsioClinic website at the following address: https://psioclinic.com/fr/alzheimer.html.
Psio has developed specific programs to date for individuals with Alzheimer’s.